187 related articles for article (PubMed ID: 8823313)
1. Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug.
Münzel T; Kurz S; Rajagopalan S; Thoenes M; Berrington WR; Thompson JA; Freeman BA; Harrison DG
J Clin Invest; 1996 Sep; 98(6):1465-70. PubMed ID: 8823313
[TBL] [Abstract][Full Text] [Related]
2. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance.
Münzel T; Sayegh H; Freeman BA; Tarpey MM; Harrison DG
J Clin Invest; 1995 Jan; 95(1):187-94. PubMed ID: 7814613
[TBL] [Abstract][Full Text] [Related]
3. Role of superoxide dismutase in in vivo and in vitro nitrate tolerance.
Münzel T; Hink U; Yigit H; Macharzina R; Harrison DG; Mülsch A
Br J Pharmacol; 1999 Jul; 127(5):1224-30. PubMed ID: 10455269
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.
Rajagopalan S; Kurz S; Münzel T; Tarpey M; Freeman BA; Griendling KK; Harrison DG
J Clin Invest; 1996 Apr; 97(8):1916-23. PubMed ID: 8621776
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a causal role of the renin-angiotensin system in nitrate tolerance.
Kurz S; Hink U; Nickenig G; Borthayre AB; Harrison DG; Münzel T
Circulation; 1999 Jun; 99(24):3181-7. PubMed ID: 10377083
[TBL] [Abstract][Full Text] [Related]
6. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C.
Heitzer T; Wenzel U; Hink U; Krollner D; Skatchkov M; Stahl RA; MacHarzina R; Bräsen JH; Meinertz T; Münzel T
Kidney Int; 1999 Jan; 55(1):252-60. PubMed ID: 9893134
[TBL] [Abstract][Full Text] [Related]
7. Prevention of nitrate tolerance with concomitant administration of hydralazine.
Elkayam U
Can J Cardiol; 1996 May; 12 Suppl C():17C-21C. PubMed ID: 8634919
[TBL] [Abstract][Full Text] [Related]
8. Evidences for prevention of nitroglycerin tolerance by carvedilol.
El-Demerdash E
Pharmacol Res; 2006 Apr; 53(4):380-5. PubMed ID: 16503407
[TBL] [Abstract][Full Text] [Related]
9. The oxidative stress concept of nitrate tolerance and the antioxidant properties of hydralazine.
Daiber A; Mülsch A; Hink U; Mollnau H; Warnholtz A; Oelze M; Münzel T
Am J Cardiol; 2005 Oct; 96(7B):25i-36i. PubMed ID: 16226933
[TBL] [Abstract][Full Text] [Related]
10. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
[TBL] [Abstract][Full Text] [Related]
11. Superoxide production in the vasculature of lipopolysaccharide-treated rats and pigs.
Javeshghani D; Hussain SN; Scheidel J; Quinn MT; Magder SA
Shock; 2003 May; 19(5):486-93. PubMed ID: 12744495
[TBL] [Abstract][Full Text] [Related]
12. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system.
Warnholtz A; Nickenig G; Schulz E; Macharzina R; Bräsen JH; Skatchkov M; Heitzer T; Stasch JP; Griendling KK; Harrison DG; Böhm M; Meinertz T; Münzel T
Circulation; 1999 Apr; 99(15):2027-33. PubMed ID: 10209008
[TBL] [Abstract][Full Text] [Related]
13. Increased superoxide production in nitrate tolerance is associated with NAD(P)H oxidase and aldehyde dehydrogenase 2 downregulation.
Szöcs K; Lassègue B; Wenzel P; Wendt M; Daiber A; Oelze M; Meinertz T; Münzel T; Baldus S
J Mol Cell Cardiol; 2007 Jun; 42(6):1111-8. PubMed ID: 17493633
[TBL] [Abstract][Full Text] [Related]
14. Prevention of nitrate tolerance by long-term treatment with statins.
Fontaine D; Otto A; Fontaine J; Berkenboom G
Cardiovasc Drugs Ther; 2003 Mar; 17(2):123-8. PubMed ID: 12975593
[TBL] [Abstract][Full Text] [Related]
15. Effects of the flavoprotein inhibitor, diphenyleneiodonium sulfate, on ex vivo organic nitrate tolerance in the rat.
Ratz JD; McGuire JJ; Anderson DJ; Bennett BM
J Pharmacol Exp Ther; 2000 May; 293(2):569-77. PubMed ID: 10773030
[TBL] [Abstract][Full Text] [Related]
16. Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolerance in experimental heart failure.
Bauer JA; Fung HL
Circulation; 1991 Jul; 84(1):35-9. PubMed ID: 1905595
[TBL] [Abstract][Full Text] [Related]
17. Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its beneficial effects on prognosis in patients with congestive heart failure.
Daiber A; Oelze M; Coldewey M; Kaiser K; Huth C; Schildknecht S; Bachschmid M; Nazirisadeh Y; Ullrich V; Mülsch A; Münzel T; Tsilimingas N
Biochem Biophys Res Commun; 2005 Dec; 338(4):1865-74. PubMed ID: 16289107
[TBL] [Abstract][Full Text] [Related]
18. Hydralazine decreases sodium nitroprusside-induced rat aortic ring relaxation and increased cGMP production by rat aortic myocytes.
Vidrio H; González-Romo P; Alvarez E; Alcaide C; Orallo F
Life Sci; 2005 Oct; 77(24):3105-16. PubMed ID: 15985267
[TBL] [Abstract][Full Text] [Related]
19. The effect of hydralazine on the development of tolerance to continuous nitroglycerin.
Parker JD; Parker AB; Farrell B; Parker JO
J Pharmacol Exp Ther; 1997 Feb; 280(2):866-75. PubMed ID: 9023301
[TBL] [Abstract][Full Text] [Related]
20. Hydralazine does not ameliorate nitric oxide resistance in chronic heart failure.
Chirkov YY; De Sciscio M; Sverdlov AL; Leslie S; Sage PR; Horowitz JD
Cardiovasc Drugs Ther; 2010 Apr; 24(2):131-7. PubMed ID: 20490904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
